CSL Seqirus at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
CSL Seqirus takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions cover influenza prevention and the front-line response to emerging outbreaks. The most concrete builds the evidence for an MF59-adjuvanted, cell-derived, higher-dose influenza vaccine.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
CSL's influenza vaccine business, making seasonal and pandemic influenza vaccines, including adjuvanted and cell-based vaccines. | Talk Wed Oct 21 10:45 Panel Wed Oct 21 10:45 Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain. |
Instantly find 20 buyers from CSL Seqirus
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction